Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach-Reference-Cited by-同舟云学术

Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach

Published:2016-04 Issue:4 Volume:3 Page:350-357
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Ruderfer Douglas M,Charney Alexander W,Readhead Ben,Kidd Brian A,Kähler Anna K,Kenny Paul J,Keiser Michael J,Moran Jennifer L,Hultman Christina M,Scott Stuart A,Sullivan Patrick F,Purcell Shaun M,Dudley Joel T,Sklar Pamela

Funder

National Institutes of Health (NIH)/National Institute of Mental Health (NIMH) ARRA Grand Opportunity

Psychiatric Research, the Stanley Medical Research Institute, NIDDK

NIH/NIGMS

NIH/NIMH

NIH/NHGRI

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference33 articles.

1. Schizophrenia: a concise overview of incidence, prevalence, and mortality;McGrath;Epidemiol Rev,2008

2. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis;Leucht;Lancet,2013

3. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review;Higashi;Ther Adv Psychopharmacol,2013

4. Biological insights from 108 schizophrenia-associated genetic loci;Nature,2014

5. A polygenic burden of rare disruptive mutations in schizophrenia;Purcell;Nature,2014

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessment;2024-07-18

2. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice;European Neuropsychopharmacology;2024-07

3. Pharmacologic and genetic evidence converge on mechanisms of psychotic illness;2024-05-01

4. Biomarkers of treatment-resistant schizophrenia: A systematic review;Neuroscience Applied;2024

5. Investigation of choroid plexus variability in schizophrenia-spectrum disorders – insights from a multimodal study;2023-12-18